| Q36691611 | A Role for the PPARgamma in Cancer Therapy. |
| Q42734250 | A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells |
| Q28580476 | Activation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor gamma with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal Development |
| Q54347900 | Activation of liver X receptor enhances the proliferation and migration of endothelial progenitor cells and promotes vascular repair through PI3K/Akt/eNOS signaling pathway activation. |
| Q42955158 | Cancer cell line specific co-factors modulate the FOXM1 cistrome |
| Q35346767 | Cellular and molecular effects of thiazolidinediones on bone cells: a review. |
| Q37029158 | Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy. |
| Q35671133 | Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol |
| Q47803246 | Chromosomal regions 22q13 and 3p25 may harbor quantitative trait loci influencing both age at menarche and bone mineral density |
| Q37021288 | Clinical Use of PPARgamma Ligands in Cancer |
| Q26784486 | Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention |
| Q37316564 | Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. |
| Q34965545 | Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic origins |
| Q36430799 | Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation |
| Q53151974 | Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. |
| Q36969586 | Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation |
| Q36377126 | Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer |
| Q36031004 | Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia |
| Q26829534 | Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases |
| Q35987100 | Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy |
| Q38029548 | Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer |
| Q24649539 | Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells |
| Q40072734 | Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells |
| Q33848732 | Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells |
| Q54157212 | Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves' ophthalmopathy. |
| Q35168034 | In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer |
| Q36957230 | Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification |
| Q36801801 | Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish |
| Q59503917 | Intracellular receptor regulation of adipose metabolism by the isoflavone genistein |
| Q36267934 | Is there an estrogenic component in the metabolic syndrome? |
| Q37173328 | Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics |
| Q38828335 | Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression |
| Q38619037 | Mediating Roles of PPARs in the Effects of Environmental Chemicals on Sex Steroids. |
| Q33637261 | Minireview: Estrogen receptor-beta: mechanistic insights from recent studies |
| Q36971797 | Minireview: nuclear receptors and breast cancer |
| Q37366222 | Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma |
| Q92376278 | Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 Breast Cancer Cells |
| Q43486137 | Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells |
| Q36642430 | PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice |
| Q37971590 | PPAR gamma, bioactive lipids, and cancer progression |
| Q36724712 | PPARgamma and PPARdelta as Modulators of Neoplasia and Cell Fate |
| Q37014943 | PPARgamma, PTEN, and the Fight against Cancer |
| Q41611974 | PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer |
| Q36303977 | PPARγ agonists target aromatase via both PGE2 and BRCA1. |
| Q44588198 | PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance |
| Q49887901 | PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy. |
| Q24316364 | Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells |
| Q36748533 | Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology |
| Q36901325 | Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility |
| Q26753843 | Prenatal Exposures to Multiple Thyroid Hormone Disruptors: Effects on Glucose and Lipid Metabolism |
| Q36375196 | Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma |
| Q47691876 | Regulation of the tumor suppressor PTEN by natural anticancer compounds |
| Q36367151 | Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells |
| Q38789308 | Role of dietary bioactive natural products in estrogen receptor-positive breast cancer |
| Q35687208 | Skp2 is a promising therapeutic target in breast cancer |
| Q42834242 | Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet |
| Q35646069 | TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction |
| Q57536451 | The Effects of Tamoxifen and Fish Oil on Mammary Carcinogenesis in Polyoma Middle T Transgenic Mice |
| Q99555913 | The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies |
| Q39561884 | The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes |
| Q47618192 | Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta-analysis. |
| Q37010188 | Thiazolidinediones as anti-cancer agents |